Here, we studied the effect of metformin and PER2 on the pentose phosphate pathway (PPP) and postulated that the strategy of using metformin to modify the circadian clock may provide an innovative way to administer chronotherapy for cancer treatment. The gene discussed is CLOCK; the disease is cancer.